133
Views
3
CrossRef citations to date
0
Altmetric
Review

Update on the Anti-Cancer Potency of Tocotrienols and α-Tocopheryl Polyethylene Glycol 1000 Succinate on Leukemic Cell Lines

ORCID Icon, , , &
Pages 1302-1308 | Received 07 Jan 2020, Accepted 27 Jun 2020, Published online: 22 Jul 2020

References

  • Evans HM, Bishop KS. On the existence of a hitherto unrecognized dietary factor essential for reproduction. Science. 1922;56(1458):650–1. doi:10.1126/science.56.1458.650
  • Peh HY, Tan WSD, Liao W, Wong W, Zhang Y. Vitamin E therapy beyond cancer: tocopherol versus tocotrienol. Pharmacol Ther. 2016;162:152–69. doi:10.1016/j.pharmthera.2015.12.003
  • Kanchi MM, Rane G, Kumar AP, Shanmugam MK, Sethi G. Tocotrienols: The unsaturated sidekick shifting new paradigms in vitamin E therapeutics. Drug Discov Today. 2017;22(12):1765–81. doi:10.1016/j.drudis.2017.08.001
  • Pierpaoli E, Viola V, Pilolli F, Piroddi M, Galli F, Provinciali M. Gamma- and delta-tocotrienols exert a more potent anticancer effect than alpha-tocopheryl succinate on breast cancer cell lines irrespective of HER-2/neu expression. Life Sci. 2010;86(17–18):668–75. doi:10.1016/j.lfs.2010.02.018
  • Lippman SM, Klein EA, Goodman PJ, Lucia MS, Thompson IM, Ford LG, Parnes HL, Minasian LM, Gaziano JM, Hartline JA, et al. Effect of selenium and vitamin E on risk of prostate cancer and other cancers: the selenium and vitamin E cancer prevention trial (SELECT). J Am Med Assoc. 2009;301(1):39–51. : doi:10.1001/jama.2008.864
  • Sailo BL, Banik K, Padmavathi G, Javadi M, Bordoloi D, Kunnumakkara AB. Tocotrienols: The promising analogues of vitamin E for cancer therapeutics. Pharmacol Res. 2018;130:259–72. doi:10.1016/j.phrs.2018.02.017
  • ATBC Cancer Prevention Study Group. The alpha-tocopherol, beta-carotenelung cancer prevention study: design, methods, participant characteristics, and compliance. Ann Epidemiol. 1994;4(1):1–10.
  • Lee I, Cook NR, Gaziano JM, Gordon D, Ridker PM, Manson JE, Hennekens CH, Buring JE. Vitamin E in the primary prevention of cardiovascular disease and cancer: the Women's Health Study: a randomized controlled trial. J Am Med Assoc. 2005;294(1):56–65. doi:10.1001/jama.294.1.56
  • Wada S, Satomi Y, Murakoshi M, Noguchi N, Yoshikawa T, Nishino H. Carcinogenesis and cancer prevention: tumor suppressive effects of tocotrienol in vivo and in vitro. Cancer Lett. 2005;229(2):181–91. doi:10.1016/j.canlet.2005.06.036
  • Hiura Y, Tachibana H, Arakawa R, Aoyama N, Okabe M, Sakai M, Yamada K. Specific accumulation of gamma- and delta-tocotrienols in tumor and their antitumor effect in vivo. J Nutr Biochem. 2009;20(8):607–13. doi:10.1016/j.jnutbio.2008.06.004
  • Jiang Q, Rao X, Kim CY, Freiser H, Zhang Q, Jiang Z, Li G. Gamma-tocotrienol induces apoptosis and autophagy in prostate cancer cells by increasing intracellular dihydrosphingosine and dihydroceramide. Int J Cancer. 2012;130(3):685–93. doi:10.1002/ijc.26054
  • Manu KA, Shanmugam MK, Ramachandran L, Li F, Fong CW, Kumar AP, Tan P, Sethi G. First evidence that γ-tocotrienol inhibits the growth of human gastric cancer and chemosensitizes it to capecitabine in a xenograft mouse model through the modulation of NF-κB pathway. Clin Cancer Res. 2012;18(8):2220–9. doi:10.1158/1078-0432.CCR-11-2470
  • Siveen KS, Ahn KS, Ong TH, Shanmugam MK, Li F, Yap WN, Kumar AP, Fong CW, Tergaonkar V, Hui KM, et al. Y-tocotrienol inhibits angiogenesis-dependent growth of human hepatocellular carcinoma through abrogation of AKT/mTOR pathway in an orthotopic mouse model. Oncotarget. 2014;5(7):1897–911. doi:10.18632/oncotarget.1876
  • Prasad S, Gupta SC, Tyagi AK, Aggarwal BB. γ-Tocotrienol suppresses growth and sensitises human colorectal tumours to capecitabine in a nude mouse xenograft model by down-regulating multiple molecules. Br J Cancer. 2016;115(7):814–24. doi:10.1038/bjc.2016.257
  • Roberts KG. Genetics and prognosis of ALL in children vs adults. Hematology Am Soc Hematol Educ Program. 2018;2018(1):137–45. doi:10.1182/asheducation-2018.1.137
  • Tham SY, Loh HS, Mai CW, Fu JF. Tocotrienols modulate a life or death decision in cancers. Int J Mol Sci. 2019;20(2):372. doi:10.3390/ijms20020372
  • NIH, National Cancer Institute. Cancer Stat Facts: NHL - Diffuse Large B-Cell Lymphoma (DLBCL). 2019. https://seer.cancer.gov/statfacts/html/dlbcl.html.
  • Bertoli S, Tavitian S, Huynh A, Borel C, Guenounou S, Luquet I, Delabesse E, Sarry A, Laurent G, Attal M, et al. Improved outcome for AML patients over the years 2000–2014. Blood Cancer J. 2017;7(12):635. doi:10.1038/s41408-017-0011-1
  • Cancer Research UK. 2019. www.cancerresearch.org.
  • Cook GJ, Pardee TS. Animal models of leukemia: any closer to the real thing? Cancer Metastasis Rev. 2013;32(1–2):63–76. doi:10.1007/s10555-012-9405-5
  • Dinner S, Platanias LC. Targeting the mTOR pathway in leukemia. J Cell Biochem. 2016;117(8):1745–52. doi:10.1002/jcb.25559
  • Ruiz-Moreno C, Jimenez-Del-Rio M, Sierra-Garcia L, Lopez-Osorio B, Velez-Pardo C. Vitamin E synthetic derivate-TPGS-selectively induces apoptosis in jurkat t cells via oxidative stress signaling pathways: Implications for acute lymphoblastic leukemia. Apoptosis. 2016;21(9):1019–32. doi:10.1007/s10495-016-1266-x
  • Shephard EA, Neal RD, Rose PW, Walter FM, Hamilton W. Symptoms of adult chronic and acute leukaemia before diagnosis: large primary care case-control studies using electronic records. Br J Gen Pract. 2016;66(644):e182–e188. doi:10.3399/bjgp16X683989
  • Haffid SR, Iran N. Tocotrienols and acute myeloid leukemia. Palm Oil Dev. 2018;68:3337.
  • Aggarwal BB, Sundaram C, Prasad S, Kannappan R. Tocotrienols, the vitamin E of the 21st century: its potential against cancer and other chronic diseases. Biochem Pharmacol. 2010;80(11):1613–31. doi:10.1016/j.bcp.2010.07.043
  • Catalgol B, Batirel S, Ozer NK. Cellular protection and therapeutic potential of tocotrienols. Curr Pharm Des. 2011;17(21):2215–20. doi:10.2174/138161211796957436
  • Cardenas E, Ghosh R. Vitamin E: a dark horse at the crossroad of cancer management. Biochem Pharmacol. 2013;86(7):845–52. doi:10.1016/j.bcp.2013.07.018
  • Constantinou C, Charalambous C, Kanakis D. Vitamin E and cancer: an update on the emerging role of γ and δ tocotrienols. Eur J Nutr. 2020;59(3):845–57. doi:10.1007/s00394-019-01962-1
  • Ahsan H, Ahad A, Iqbal J, Siddiqui WA. Pharmacological potential of tocotrienols: a review. Nutr Metab (Lond)). 2014;11(1):52. doi:10.1186/1743-7075-11-52
  • Tang K, Liu J, Russell P, Clements J, Ling M-T. Gamma tocotrienol induces apoptosis in prostate cancer cells by targeting the Ang-1/Tie-2 signalling pathway. Int J Mol Sci. 2019;20(5):1164. pii: doi:10.3390/ijms20051164,
  • Weng-Yew W, Selvaduray KR, Ming CH, Nesaretnam K. Suppression of tumor growth by palm tocotrienols via the attenuation of angiogenesis. Nutr Cancer. 2009;61(3):367–73. doi:10.1080/01635580802582736
  • Liu H, Wang Q, Li Y, Sun W, Liu J, Yang Y, Xu W, Sun X, Chen B. Inhibitory effects of gamma-tocotrienol on invasion and metastasis of human gastric adenocarcinoma SGC-7901 cells. J Nutr Biochem. 2010;21(3):206–13. doi:10.1016/j.jnutbio.2008.11.004
  • De Silva L, Chuah LH, Meganathan P, Fu J. Tocotrienol and cancer metastasis. Biofactors. 2016;42(2):149–62. doi:10.1002/biof.1259
  • Guo Y, Luo J, Tan S, Otieno BO, Zhang Z. The applications of vitamin E TPGS in drug delivery. Eur J Pharm Sci. 2013;49(2):175–86. doi:10.1016/j.ejps.2013.02.006
  • Constantinou C, Neophytou C, Vraka P, Hyatt J, Papas K, Constantinou A. Induction of DNA damage and caspase-independent programmed cell death by vitamin E. Nutr Cancer. 2012;64(1):136–52. doi:10.1080/01635581.2012.630167
  • Neophytou CM, Constantinou C, Papageorgis P, Constantinou AI. D-alpha-tocopheryl polyethylene glycol succinate (TPGS) induces cell cycle arrest and apoptosis selectively in survivin-overexpressing breast cancer cells. Biochem Pharmacol. 2014;89(1):31–42. doi:10.1016/j.bcp.2014.02.003
  • Guan X, Gao M, Liu H, Lv L, Deng S, Gao D, Tian Y, Xu H, Zhang C. Quercetin-loaded poly (lactic-co-glycolic acid)-d-α-tocopheryl polyethylene glycol 1000 succinate nanoparticles for the targeted treatment of liver cancer. Drug Deliv. 2016;23(9):3307–18. doi:10.1080/10717544.2016.1176087
  • Singh RP, Sharma G, Sonali Singh S, Kumar M, Pandey BL, Koch B, Muthu MS. Vitamin E TPGS conjugated carbon nanotubes improved efficacy of docetaxel with safety for lung cancer treatment. Colloids Surf B Biointerfaces. 2016;141:429–42. doi:10.1016/j.colsurfb.2016.02.011
  • Bernabeu E, Gonzalez L, Cagel M, Gergic EP, Moretton MA, Chiappetta DA. Novel Soluplus(®)-TPGS mixed micelles for encapsulation of paclitaxel with enhanced in vitro cytotoxicity on breast and ovarian cancer cell lines. Colloids Surf B Biointerfaces. 2016;140:403–11. doi:10.1016/j.colsurfb.2016.01.003
  • Youk H, Lee E, Choi M, Lee Y, Chung JH, Kim S, Lee C, Lim S. Enhanced anticancer efficacy of alpha-tocopheryl succinate by conjugation with polyethylene glycol. J Control Release. 2005;107(1):43–52. doi:10.1016/j.jconrel.2005.05.014
  • Zhao P, Li L, Zhou S, Qiu L, Qian Z, Liu X, Cao X, Zhang H. TPGS functionalized mesoporous silica nanoparticles for anticancer drug delivery to overcome multidrug resistance. Mater Sci Eng C Mater Biol Appl. 2018;84:108–17. doi:10.1016/j.msec.2017.11.040
  • Wong RSY, Radhakrishnan AK, Ibrahim TAT, Cheong S. Delta- and gamma-tocotrienols induce classical ultrastructural apoptotic changes in human t lymphoblastic leukemic cells. Microsc Microanal. 2012;18(3):462–9. doi:10.1017/S1431927612000177
  • Yamasaki M, Nishimura M, Sakakibara Y, Suiko M, Morishita K, Nishiyama K. Delta-tocotrienol induces apoptotic cell death via depletion of intracellular squalene in ED40515 cells. Food Funct. 2014;5(11):2842–9. doi:10.1039/c4fo00635f
  • Ahn KS, Sethi G, Krishnan K, Aggarwal BB. Gamma-tocotrienol inhibits nuclear factor-kappaB signaling pathway through inhibition of receptor-interacting protein and TAK1 leading to suppression of antiapoptotic gene products and potentiation of apoptosis. J Biol Chem. 2007;282(1):809–20. doi:10.1074/jbc.M610028200
  • Inoue A, Takitani K, Koh M, Kawakami C, Kuno T, Tamai H. Induction of apoptosis by γ-tocotrienol in human cancer cell lines and leukemic blasts from patients: dependency on bid, cytochrome c, and caspase pathway. Nutr Cancer. 2011;63(5):763–70. doi:10.1080/01635581.2011.563030
  • de Mesquita ML, Araújo RM, Bezerra DP, Filho RB, de Paula JE, Silveira ER, Pessoa C, de Moraes MO, Costa Lotufo LV, Espindola LS. Cytotoxicity of δ-tocotrienols from Kielmeyera coriacea against cancer cell lines . Bioorg Med Chem. 2011;19(1):623–30. doi:10.1016/j.bmc.2010.10.044
  • Chen C, Liu T, Huang S, Ho C, Huang T. Differentiation and apoptosis induction by lovastatin and γ-tocotrienol in HL-60 cells via ras/ERK/NF-κB and ras/akt/NF-κB signaling dependent down-regulation of glyoxalase 1 and HMG-CoA reductase. Cell Signal. 2015;27(11):2182–90. doi:10.1016/j.cellsig.2015.07.014
  • Rizk S, Ghanem P, Zouein A, Hodroj MH. Effects of vitamin E derivatives on the proliferation of KG-1 leukemic cells in vitro. FASEB J. 2007;31(1_supplement):790.5.
  • Mohamad MR. The vitamin E derivative gamma tocotrienol promotes anti-tumor effects in acute myeloid leukemia cell lines. 2019. DOI: 10.26756/th.2019.131.
  • Lee NK, Radhakrishnan AK, Selvaduray KR. Apoptosis gene network regulated by delta-tocotrienol in K562 chronic myeloid leukaemia cells. J Oil Palm Res. 2017;29:251–61.
  • Ng KL, Radhakrishnan AK, Selvaduray KR. Gamma-tocotrienol inhibits proliferation of human chronic myeloid leukemic cells via activation of extrinsic and intrinsic apoptotic pathways. J Blood Disorders Ther. 2016;1(1):102.
  • Ghanem P, Zouein A, Mohamad M, Hodroj MH, Haykal T, Abou Najem S, Naim HY, Rizk S. The vitamin E derivative gamma tocotrienol promotes anti-tumor effects in acute myeloid leukemia cell lines. Nutrients. 2019;11(11):E2808. doi:10.3390/nu11112808
  • Constantinou C, Papas K, Constantinou A. Caspase-independent pathways of programmed cell death: The unraveling of new targets of cancer therapy? Curr Cancer Drug Targets. 2009;9(6):717–28. doi:10.2174/156800909789271512
  • Clinical trials. 2019. https://clinicaltrials.gov/.
  • Al-Tonbary Y, Al-Haggar M, El-Ashry R, El-Dakroory S, Azzam H, Fouda A. Vitamin E and N-Acetylcysteine as antioxidant adjuvant therapy in children with Acute Lymphoblastic Leukemia. Adv Heamatol. 2009;2009:5.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.